Reportstack

Repligen Corporation - Product Pipeline Review - 2012 New Report

 

Naperville, IL -- (ReleaseWire) -- 09/20/2012 -- Repligen Corporation - Product Pipeline Review - 2012 provides data on the Repligen Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Repligen Corporation - Brief Repligen Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Repligen Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Repligen Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Repligen Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Repligen Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Repligen Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Repligen Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Repligen Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Repligen Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Repligen Corporation; Repligen Corporation - Key Therapeutics; Repligen Corporation - Pipeline Overview and Promising Molecules; Repligen Corporation - News; Repligen Corporation - Latest Updates; Repligen Corporation - Pipeline; Repligen Corporation - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89906/repligen-corporation-product-pipeline-review-2012.html